⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL27581994 | 0.98 | NPC1 (0.41) | — | |
| SCHEMBL28723730 | 0.83 | TYK2 (0.37) | — | |
| SCHEMBL4419122 | 0.83 | — | — | |
| SCHEMBL29994134 | 0.82 | RAB9A (0.39) | — | |
| SCHEMBL28509431 | 0.81 | GAA (0.46) | — | |
| SCHEMBL2462955 | 0.80 | — | — | |
| SCHEMBL3081010 | 0.80 | — | — | |
| SCHEMBL29084179 | 0.78 | — | — | |
| SCHEMBL4502786 | 0.78 | — | — | |
| SCHEMBL11115402 | 0.78 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117946081-A | Mass spectrum cleavable abnormal-shaped difunctional crosslinking agent and preparation method and application thereof | 吉林大学 | 2024-04-30 | — | — | CN | claimed |
| CN-111818995-B | Urea impregnated zeolite adsorbent and method of making same | 3M创新有限公司 | 2024-01-26 | — | — | CN | claimed |
| CN-116574067-A | Mass spectrum cleavable tyrosine selective cross-linking agent and preparation method and application thereof | 吉林大学 | 2023-08-11 | — | — | CN | claimed |
| CN-111801301-A | Methods and compositions for reducing azole and AOX corrosion inhibitors | BL 科技公司 | 2020-10-20 | — | — | CN | claimed |
| CN-1327418-A | Metallic ink composition for wick type writing instruments | DRI MARK PRODUCTS INC (US) | 2001-12-19 | — | — | CN | claimed |
| CN-117986716-B | Medium-high voltage special cable material and preparation method thereof | 南方珠江科技有限公司 | 2024-06-25 | — | — | CN | disclosed |
| CN-117986716-A | Medium-high voltage special cable material and preparation method thereof | 南方珠江科技有限公司 | 2024-05-07 | — | — | CN | disclosed |
| CN-117946081-A | Mass spectrum cleavable abnormal-shaped difunctional crosslinking agent and preparation method and application thereof | 吉林大学 | 2024-04-30 | — | — | CN | disclosed |
| CN-117794898-A | 3-pyrrolylsulfonamide compounds as GPR17 antagonists | 瑞文德医疗公众有限公司 | 2024-03-29 | — | — | CN | disclosed |
| CN-111818995-B | Urea impregnated zeolite adsorbent and method of making same | 3M创新有限公司 | 2024-01-26 | — | — | CN | disclosed |
| CN-116574067-A | Mass spectrum cleavable tyrosine selective cross-linking agent and preparation method and application thereof | 吉林大学 | 2023-08-11 | — | — | CN | disclosed |
| CN-115197156-A | Dual-functionalized protein cross-linking agent and preparation and application thereof | 吉林大学 | 2022-10-18 | — | — | CN | disclosed |
| CN-101472925-A | As adenosine A2APurine derivatives of receptor agonists | NOVARTIS AG (CH) | 2009-07-01 | — | — | CN | disclosed |
| CN-101277946-A | Heterocyclylamide-substituted thiazoles, pyrroles and thiophenes | BAYER HEALTHCARE AG (DE) | 2008-10-01 | — | — | CN | disclosed |
| EP-1960394-A2 | PYRAZOLYL UREA DERIVATIVES USEFUL IN THE TREATMENT OF CANCER | Bayer HealthCare AG (DE) | 2008-08-27 | — | — | EP | disclosed |
| CN-100347161-C | PNA monomer and precursor | PANAGENE INC (KR) | 2007-11-07 | — | — | CN | disclosed |
| WO-2007059202-A2 | PYRAZOLYL UREA DERIVATIVES USEFUL IN THE TREATMENT OF CANCER | BAYER HEALTHCARE AG (DE) | 2007-05-24 | — | — | WO | disclosed |
| CN-1659153-A | PNA monomer and precursor | PANAGENE INC (KR) | 2005-08-24 | — | — | CN | disclosed |
| CN-1053189-C | pyridazino quinoline compounds | ZENECA LTD (GB) | 2000-06-07 | — | — | CN | disclosed |
| CN-1138332-A | Pyridazinoquinoline compounds | ZENECA LTD (GB) | 1996-12-18 | — | — | CN | disclosed |